Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions.
Salivary gland carcinomas (SGCs) represent a rare and heterogeneous group of malignancies accounting for 3–6% of all head and neck cancers. While surgical resection and radiotherapy remain the standard for locoregional control, systemic treatment is indicated for recurrent or metastatic disease. Adv...
| Publicado en: | Current Oncology Vol. 32; no. 4; pp. 232 - 257 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Apr2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |